Stocks and Investing
Stocks and Investing
Wed, January 10, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, January 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jayson Bedford Maintained (ANGO) at Buy with Decreased Target to $10 on, Jan 9th, 2024
Jayson Bedford of Raymond James, Maintained "AngioDynamics, Inc." (ANGO) at Buy with Decreased Target from $12 to $10 on, Jan 9th, 2024.
Jayson has made no other calls on ANGO in the last 4 months.
There are 2 other peers that have a rating on ANGO. Out of the 2 peers that are also analyzing ANGO, 0 agree with Jayson's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jayson
- Yi Chen of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Monday, January 8th, 2024
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $17 on, Thursday, October 5th, 2023
Contributing Sources